Abstract
Anti-helicobater therapy and its effect on small intestinal overgrowth syndrome in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have